The EFfect of FinErenone in Kidney TransplantiOn Recipients: The EFFEKTOR Study
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Amy Mottl, MD, MPH
University of North Carolina, Chapel Hill
Principal Investigator - Prabir Roy-Chaudhury, MD, PhD
University of North Carolina, Chapel Hill
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
1 registered facility, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Unc Eastowne Kidney Transplant Clinic
Chapel Hill, North Carolina, United States
Amy Mottl, MD, MPHCharles Jennette, MDElizabeth Kotzen, MD, MSCRMark Kleman, DOPrabir Roy-Chaudhury, MD, PhDRandal Detwiler, MDRecruiting
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 23 Apr 2024
- Primary completion
- 31 Mar 2027
- Completion
- 31 Dec 2027
- Last update posted
- 14 Apr 2026
- Registered enrollment
- 100
- Registry id
- NCT06059664
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.